Harnessing the sponge microbiome for industrial biocatalysts

被引:21
|
作者
Rodrigues de Oliveira, Bruno Francesco [1 ,2 ]
Carr, Clodagh M. [2 ]
Dobson, Alan D. W. [2 ,3 ]
Laport, Marinella Silva [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil
[2] Univ Coll Cork, Sch Microbiol, Cork, Ireland
[3] Univ Coll Cork, Environm Res Inst, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
Bacteria; Biodiscovery; Enzymes; Industrial applications; Marine biotechnology; Sponge holobiont; MARINE-BACTERIA; IN-VITRO; PSEUDOALTEROMONAS-AGARIVORANS; BIOCHEMICAL-CHARACTERIZATION; ENZYMATIC HALOGENATION; AGGREGATION FACTOR; SP NOV; ENZYMES; FUNGAL; LIPASE;
D O I
10.1007/s00253-020-10817-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Within the marine sphere, host-associated microbiomes are receiving growing attention as prolific sources of novel biocatalysts. Given the known biocatalytic potential of poriferan microbial inhabitants, this review focuses on enzymes from the sponge microbiome, with special attention on their relevant properties and the wide range of their potential biotechnological applications within various industries. Cultivable bacterial and filamentous fungal isolates account for the majority of the enzymatic sources. Hydrolases, mainly glycoside hydrolases and carboxylesterases, are the predominant reported group of enzymes, with varying degrees of tolerance to alkaline pH and growing salt concentrations being common. Prospective areas for the application of these microbial enzymes include biorefinery, detergent, food and effluent treatment industries. Finally, alternative strategies to identify novel biocatalysts from the sponge microbiome are addressed, with an emphasis on modern -omics-based approaches that are currently available in the enzyme research arena. By providing this current overview of the field, we hope to not only increase the appetite of researchers to instigate forthcoming studies but also to stress how basic and applied research can pave the way for new biocatalysts from these symbiotic microbial communities in a productive fashion.
引用
收藏
页码:8131 / 8154
页数:24
相关论文
共 50 条
  • [21] Harnessing the microbiome to restore immunotherapy response
    Bullman, Susan
    Eggermont, Alexander
    Johnston, Christopher D.
    Zitvogel, Laurence
    NATURE CANCER, 2021, 2 (12) : 1301 - 1304
  • [22] Harnessing the microbiome to restore immunotherapy response
    Susan Bullman
    Alexander Eggermont
    Christopher D. Johnston
    Laurence Zitvogel
    Nature Cancer, 2021, 2 : 1301 - 1304
  • [23] Harnessing the Microbiome to Enhance Cancer Immunotherapy
    Nelson, Michelle H.
    Diven, Marshall A.
    Huff, Logan W.
    Paulos, Chrystal M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [24] Harnessing the Microbiome to Improve Drug Therapy
    Kelly, Libusha
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) : 287 - 289
  • [25] Discovery of novel biocatalysts and their industrial applications.
    Steer, BA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U135 - U136
  • [26] Industrial applications of immobilized nano-biocatalysts
    Razzaghi, Mozhgan
    Homaei, Ahmad
    Vianello, Fabio
    Azad, Taha
    Sharma, Tanvi
    Nadda, Ashok Kumar
    Stevanato, Roberto
    Bilal, Muhammad
    Iqbal, Hafiz M. N.
    BIOPROCESS AND BIOSYSTEMS ENGINEERING, 2022, 45 (02) : 237 - 256
  • [27] An update on smart biocatalysts for industrial and biomedical applications
    Shakya, Akhilesh Kumar
    Nandakumar, Kutty Selva
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2018, 15 (139)
  • [28] Recent advances in the evolutionary engineering of industrial biocatalysts
    Winkler, James D.
    Kao, Katy C.
    GENOMICS, 2014, 104 (06) : 406 - 411
  • [29] Directed evolution: tailoring biocatalysts for industrial applications
    Kumar, Ashwani
    Singh, Suren
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2013, 33 (04) : 365 - 378
  • [30] Improved β-lactam acylases and their use as industrial biocatalysts
    Sio, CF
    Quax, WJ
    CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (04) : 349 - 355